Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
- PMID: 22559838
- PMCID: PMC3488570
- DOI: 10.1186/1477-7819-10-77
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
Abstract
Background: Pancreatic adenocarcinoma (PCA) is one of the most lethal human malignancies, and radical surgery remains the cornerstone of treatment. After resection, the overall 5-year survival rate is only 10% to 29%. At the time of presentation, however, about 40% of patients generally have distant metastases and another 40% are usually diagnosed with locally advanced cancers. The remaining 20% of patients are indicated for surgery on the basis of the results of preoperative imaging studies; however, about half of these patients are found to be unsuitable for resection during surgical exploration. In the current study, we aimed to determine the clinicopathological characteristics that predict the resectability of PCA and to conduct a prognostic analysis of PCA after resection to identify favorable survival factors.
Methods: We retrospectively reviewed the medical files of 688 patients (422 men and 266 women) who had undergone surgery for histopathologically proven PCA in the Department of Surgery at Chang Gung Memorial Hospital in Taiwan from 1981 to 2006. We compared the clinical characteristics of patients who underwent resection and patients who did not undergo resection in order to identify the predictive factors for successful resectability of PCA, and we conducted prognostic analysis for PCA after resection.
Results: A carbohydrate antigen 19-9 (CA 19-9) level of 37 U/ml or greater and a tumor size of 3 cm or more independently predicted resectability of PCA. In terms of survival after resection, PCA patients with better nutritional status (measured as having an albumin level greater than 3.5 g/dl), radical resection, early tumor stage and better-differentiated tumors were associated with favorable survival.
Conclusions: Besides traditional imaging studies, preoperative CA 19-9 levels and tumor size can also be used to determine the resectability of PCA. Better nutritional status, curative resection, early tumor stage and well-differentiated tumors predict the favorable prognosis of PCA patients after resection.
Figures


Similar articles
-
Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection.World J Gastroenterol. 2009 Sep 14;15(34):4305-10. doi: 10.3748/wjg.15.4305. World J Gastroenterol. 2009. PMID: 19750574 Free PMC article.
-
A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study.Surgery. 2014 Mar;155(3):457-67. doi: 10.1016/j.surg.2013.10.024. Epub 2013 Nov 2. Surgery. 2014. PMID: 24462074
-
Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.JAMA Surg. 2016 Apr;151(4):338-45. doi: 10.1001/jamasurg.2015.4239. JAMA Surg. 2016. PMID: 26581025
-
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.Dan Med J. 2012 Dec;59(12):B4568. Dan Med J. 2012. PMID: 23290296 Review.
-
Screening for pancreatic cancer: why, how, and who?Ann Surg. 2013 Jan;257(1):17-26. doi: 10.1097/SLA.0b013e31825ffbfb. Ann Surg. 2013. PMID: 22895395 Free PMC article. Review.
Cited by
-
Ploidy and DNA index as prognostic factors in resected pancreatic ductal adenocarcinoma - a review of the literature.Prz Gastroenterol. 2014;9(6):313-6. doi: 10.5114/pg.2014.47892. Epub 2014 Dec 30. Prz Gastroenterol. 2014. PMID: 25653724 Free PMC article. Review.
-
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas.Tumour Biol. 2016 Feb;37(2):1959-66. doi: 10.1007/s13277-015-3986-x. Epub 2015 Sep 3. Tumour Biol. 2016. PMID: 26334620
-
A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score.Cancers (Basel). 2020 Mar 25;12(4):783. doi: 10.3390/cancers12040783. Cancers (Basel). 2020. PMID: 32218346 Free PMC article.
-
RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer.Biomedicines. 2024 Jan 16;12(1):199. doi: 10.3390/biomedicines12010199. Biomedicines. 2024. PMID: 38255305 Free PMC article.
-
Surgical exploration without resection in pancreatic and periampullary tumors: Report from a national database.Scand J Surg. 2021 Sep;110(3):344-350. doi: 10.1177/1457496920913669. Epub 2020 Apr 17. Scand J Surg. 2021. PMID: 32299289 Free PMC article.
References
-
- American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society; 2008. http://www.cancer.org/acs/groups/content/@nho/documents/document/2008caf....
-
- Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226:248–260. doi: 10.1097/00000658-199709000-00004. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical